Raffa, Jesse D.

Publishing since 2006 (Baby)

Has published 12 publications in 5 years

Number of publications published per year by Raffa, Jesse D.. (Source : PubMed)

Distribution of publications types for Raffa, Jesse D.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Grebely J, Raffa JD, Lai C, Kerr T, Fischer B, Krajden M, Dore GJ, Tyndall MW. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents. J. Viral Hepat. 2010
Tossonian HK, Raffa JD, Grebely J, Viljoen M, Mead A, Khara M, McLean M, Krishnamurthy A, DeVlaming S, Conway B. Primary drug resistance in antiretroviral-naïve injection drug users. Int. J. Infect. Dis. 2009;13;5
Grebely J, Raffa JD, Lai C, Krajden M, Kerr T, Fischer B, Tyndall MW. Low uptake of treatment for hepatitis C virus infection in a large community-based study of inner city residents. J. Viral Hepat. 2009;16;5
Raffa JD, Tossonian HK, Grebely J, Petkau AJ, DeVlaming S, Conway B. Intermediate highly active antiretroviral therapy adherence thresholds and empirical models for the development of drug resistance mutations. J. Acquir. Immune Defic. Syndr. 2008;47;3
Grebely J, Genoway KA, Raffa JD, Dhadwal G, Rajan T, Showler G, Kalousek K, Duncan F, Tyndall MW, Fraser C, Conway B, Fischer B. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug Alcohol Depend 2008;93;1-2
Grebely J, Genoway K, Khara M, Duncan F, Viljoen M, Elliott D, Raffa JD, DeVlaming S, Conway B. Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection. Int. J. Drug Policy 2007;18;5
Grebely J, Raffa JD, Meagher C, Duncan F, Genoway KA, Khara M, McLean M, Mead A, Viljoen M, DeVlaming S, Fraser C, Conway B. Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users. J. Gastroenterol. Hepatol. 2007;22;9
Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, Mead A, McLean M, Duncan F, Petkau AJ, DeVlaming S, Conway B. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Drug Alcohol Depend 2007;89;2-3
Grebely J, Raffa JD, Lai C, Krajden M, Conway B, Tyndall MW. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Can. J. Gastroenterol. 2007;21;7
Tossonian HK, Raffa JD, Grebely J, Trotter B, Viljoen M, Mead A, Khara M, McLean M, Duncan F, Fraser C, DeVlaming S, Conway B. Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy program. J. Acquir. Immune Defic. Syndr. 2007;45;3

[ See timeline ] [ See all publications ]

h=9

means that Raffa, Jesse D. has 9 papers cited a least 9 times - methodology

Key figures

12 pub in 5 years
2.4 publications/year
best year 2007 with 6 pub
h-index 9 with 12 pub
h-ratio : 75 %

See Timeline

Ranking

It's me !

Click here if you are
Raffa, Jesse D..

Most frequent Journals

J. Viral Hepat. (2x)
Drug Alcohol Depend (2x)
J. Acquir. Immune Defic. Syndr. (2x)
Int. J. Infect. Dis. (1x)
J. Gastroenterol. Hepatol. (1x)

Main affiliation

Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, V6T 1Z3, Canada.

Latest co-workers

Conway B DeVlaming S Duncan F Fischer B Fraser C Genoway K Genoway KA Grebely J Kerr T Khara M Krajden M Krishnamurthy A Lai C McLean M Mead A Petkau AJ Tossonian HK Trotter B Tyndall MW Viljoen M

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.